--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "OncoPower" developer_entity: "Witty Health" bundle_id: "com.oncopower.oncopowerapp" app_store_id: "1466384848" category: "Health & Fitness" primary_platform: "ios" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2023-08-17" report_date: "2026-05-14" last_verified: "2026-05-14T00:00:00.000Z" report_version: "1.3.41" total_reviews: 87 overall_rating: 4.6 confidence: "low" confidence_score: 0.3 data_age_days: 94 momentum_velocity: "zombie" intelligence_version: 3 competitor_count: 6 tags: ["health & fitness", "freemium", "mobile app", "app review", "app analysis", "cancer", "patients,", "caregivers,"] canonical_url: "https://marlvel.ai/apps/oncopower" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # OncoPower Intelligence Report ## TL;DR {#tldr} - **Category**: Health & Fitness · Freemium - **Signal**: Rating 4.6 > **TL;DR:** OncoPower is a health & fitness app by Witty Health, rated 4.6/5 by 87 users, available on iOS. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** OncoPower is a health & fitness app by Witty Health. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.6/5 (87 reviews) | | **Category** | Health & Fitness | | **Developer** | Witty Health | | **Pricing** | Freemium | | **Platforms** | iOS | | **Confidence** | Low (0.3/1.0) | | **Data Age** | 94d | ## Metadata & Market Performance - **Publisher:** Witty Health - **Category:** Health & Fitness - **Target Audience:** Cancer patients, caregivers, and healthcare professionals seeking integrated clinical tools and social support. - **Platforms:** iOS - **Version Reviewed:** 1.3.41 - **Report Date:** 2026-05-14 - **Signal Count:** 87 reviews analyzed - **Confidence:** Low (0.3/1.0) - **App Store ID (iOS):** 1466384848 - **Bundle ID:** com.oncopower.oncopowerapp - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-05-14 ## Executive Snapshot **What it is:** OncoPower is a social and care support app for cancer patients and caregivers, providing clinical tools and education on iOS. **Why users hire it:** Users hire OncoPower to consolidate fragmented cancer journey management into a single interface, reducing the logistical burden of coordinating clinical trials and medication costs. ## App DNA (Features & Intent) - **[Differentiator] Ask-a-Doc:** Private, unlimited Q&A with healthcare professionals via in-app subscription * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Medication Savings Suite:** Pill reminders integrated with Mark Cuban Cost Plus Drug Company pricing * *User Intent:* Users want timely prompts to stay engaged without missing updates. - **[Differentiator] Clinical Trials Matching:** Automated trial matching supported by oncology nurse navigators ## Market Position {#market-position} OncoPower maintains a niche position in the Health & Fitness category, anchored by a 4.6-star rating across 87 reviews on iOS. The lack of recent updates since August 2023 suggests a maintenance-mode posture that risks losing ground to competitors with active development cycles. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free access to social, education, and clinical tools, Paid subscription for Ask-a-Doc service - **Analysis:** Freemium model provides broad utility to drive user acquisition while gating professional clinical access behind a paid subscription. ## SWOT Analysis {#swot} **Core Strengths:** - Integrated clinical-social support model creates high switching costs - Mark Cuban Cost Plus Drug Company partnership provides tangible cost-saving mechanism **Growth Levers:** - Expansion into wearable health monitoring integration - Untapped B2B distribution through oncology clinic partnerships ## Recent Changes (v2 → v3) {#recent-changes} The platform's competitive positioning has shifted to address the market's move toward 24/7 virtual care, highlighting a critical gap in real-time clinical assistance. **Overall trend**: Stable **Compared at**: 2026-05-14 ### High-impact changes - **[Shifted] Clinical Response Focus** (positioning) - **[Added] Real-time Support Gap** (swot) ### Medium-impact changes - **[Removed] Competitive Threat Refresh** (swot) ## What's New - **Latest (v1.3.41, 2 years ago):** General bug fixes and performance improvements. ## App Momentum (Zombie) {#momentum} - No major feature updates since 2023. - Maintains stable 4.6-star rating. > **Cadence:** 1 total versions · 0 majors in last 6 months · 1000 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} OncoPower is an established health & fitness app that is free with in-app purchases. It holds a 4.6/5 rating from 87 reviews. > **Bottom Line:** OncoPower provides a valuable centralized hub for cancer care, but the stagnant update cadence leaves it vulnerable to competitors with 24/7 virtual care, so the team must prioritize real-time support to defend its market position. **Best for:** Cancer patients, caregivers, and healthcare professionals seeking integrated clinical tools and social support. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Ship real-time video support because competitors like VisionAssist+ capture immediate patient needs → increase user retention ### Feature Gaps vs Competitors - Real-time live video assistance (available in VisionAssist+) ### Outlook: Stable The digital health navigation market is shifting toward 24/7 virtual care and automated logistical support. OncoPower's current feature set is stable but lacks the aggressive development cadence required to compete with enterprise-backed rivals, so the PM must shift from maintenance to active feature expansion to remain relevant. - 🔴 The absence of feature updates since August 2023 signals a maintenance-mode posture, which risks eroding user trust against active competitors. - ⚪ The 4.6-star rating baseline indicates the current feature set meets core user needs, but lacks the momentum to attract new segments. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.6/5 | | Total Reviews | 87 | | Confidence | Low | | Pricing Model | Freemium | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Stable | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **OncoPower** (this app) | 4.6/5 | N/A | Witty Health | | [Accolade, Inc.](https://marlvel.ai/apps/accolade-inc) | 4.8/5 | N/A | Accolade, Inc. | | [GotCGM Watchface Analog](https://marlvel.ai/apps/gotcgm-watchface-analog) | N/A/5 | N/A | Gluroo Imaginations Inc. | | [GotCGM Watchface Digital](https://marlvel.ai/apps/gotcgm-watchface-digital) | N/A/5 | N/A | Gluroo Imaginations Inc. | | [Cariloop](https://marlvel.ai/apps/cariloop) | 4.6/5 | N/A | Cariloop, Inc. | | [Modern Animal](https://marlvel.ai/apps/modern-animal) | 4.9/5 | Excited | Modern Animal, Inc. | ## Company Profile - **Developer:** Witty Health ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/oncopower/id1466384848?uo=4) - **Sources:** App store metadata. ## Related Intel Reports - [*Accolade, Inc.*](https://marlvel.ai/apps/accolade-inc) (Accolade, Inc.) · 4.8/5 Rating - [*GotCGM Watchface Analog*](https://marlvel.ai/apps/gotcgm-watchface-analog) (Gluroo Imaginations Inc.) · N/A Rating - [*GotCGM Watchface Digital*](https://marlvel.ai/apps/gotcgm-watchface-digital) (Gluroo Imaginations Inc.) · N/A Rating - [*Cariloop*](https://marlvel.ai/apps/cariloop) (Cariloop, Inc.) · 4.6/5 Rating - [*Modern Animal*](https://marlvel.ai/apps/modern-animal) (Modern Animal, Inc.) · 4.9/5 Rating | Positive Sentiment - [*VisionAssist+*](https://marlvel.ai/apps/visionassist) (Coding Minds, Inc.) · 5.0/5 Rating - [*Taller AI: Height Maximizer*](https://marlvel.ai/apps/taller-ai-height-maximizer) (Leadimize) · 4.7/5 Rating | Positive Sentiment - [*TallerTeen - Grow Taller Now*](https://marlvel.ai/apps/tallerteen-grow-taller-now) (Viral App Developement LLC) · 4.6/5 Rating | Positive Sentiment - [*GoTall - Height Predictor*](https://marlvel.ai/apps/gotall-height-predictor) (Super Viral Studio) · 4.7/5 Rating - [*Strava: Run, Bike, Walk*](https://marlvel.ai/apps/strava-run-bike-walk) (Strava, Inc.) · 4.7/5 Rating | Positive Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 87 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 94 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/oncopower) Data licensed for AI Agent attribution under CC-BY-NC 4.0.